Tags: cancer

All Categories (1-20 of 101)

  1. [Illinois] Cancer Community Symposium 2012: A Sensitivity Scale for Targeting T Cells with Chimeric Antigen Receptors (CAR) and Bispecific T Cell Engagers (BiTE)

    09 May 2012 | | Contributor(s):: Jennifer Stone

    Using a patients immune system to target cancer and maintain long-term surveillance is an attractive goal. Although T cells can respond potently to tumors, immune tolerance mechanisms often result in deletion or inactivation of those T cells expressing specific T cell receptors (TCRs) against...

  2. [Illinois] Cancer Community Symposium 2012: DriveRank: Discovering Patient-Specific Driver Mutations

    09 May 2012 | | Contributor(s):: Jack Pu Hou

    One of the pressing challenges in cancer genomics is to distinguish driver mutations (i.e. mutations involved in tumorigenesis) and passenger mutations (i.e. functionally neutral mutations). Current approaches to identifying driver mutations in cancer look for recurrent events in multiple...

  3. [Illinois] Cancer Community Symposium 2012: Elevated Estrogen Signaling Drives Tumorigenesis in a Novel Animal Model for Ovarian Epithelial Cancer

    09 May 2012 | | Contributor(s):: Mary Jo Laws

    We generated a mouse model where aberrant estrogen receptor alpha (Esr1) signaling in the hypothalamo-pituitary-ovarian axis leads to ovarian tumorigenesis. In this model, termed Esr1d/d, the Esr1 gene is selectively deleted in the anterior pituitary. The Esr1d/d mice form palpable ovarian tumors...

  4. 2005 Oncological Sciences Center Symposium

    16 Aug 2005 |

    Progress and Problems inCancer Treatment and Prevention

  5. 2005 Oncological Sciences Center Symposium Agenda

    07 Dec 2006 |

  6. 2008 BioNano Technology and Pharmaceuticals

    06 Aug 2008 | | Contributor(s):: Pankaj Sharma, Nalam Madhusudhana Rao

    The purpose of this symposium is to bring together top scientists from India and the United States to present their latest work and to discuss future international scientific collaborative partnerships. This one and a half day symposium will also feature a special second half day mini-symposium...

  7. Nov 16 2015

    4th Oncology Partnering & Deal-Making Conference

    Dear Colleague,We invite you to attend the 4th Oncology Partnering & Deal-Making Conference, which will take place November 16-17, 2015 in San Francisco, CA. This event is a partnership and...

    http://nanohub.org/events/details/1375

  8. Jul 07 2014

    5th Cancer Targets & Therapeutics Conference

    With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and...

    http://nanohub.org/events/details/970

  9. Adi Prcike

    I am just a regular dude, I have been blogging online since 1995, I like to talk about the tao of badass.

    http://nanohub.org/members/70904

  10. Antiestrogenic Conjugates as New Breast Cancer Chemoprevention Agents

    08 Mar 2007 | | Contributor(s):: Ross Weatherman

    Tamoxifen is the first drug specifically approved for the prevention of cancer and arguably the most successful anticancer drug of all time. Although millions of breast cancer patients have benefited from tamoxifen therapy, there are side effects that hinder the broad use of tamoxifen as a...

  11. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.13.1      Bringing in-vivo considerations into NMS design13.1.1    the in-vitro to ex-vivo to in-vivo paradigm         13.1.1.1 In-vitro - importance of choosing...

  12. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.14.1      Introduction to integrated designs14.1.1    “Total design” but there is some order in the design process14.1.2    A brief outline of the total design...

  13. BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

    02 Dec 2011 | | Contributor(s):: Deborah W Knapp

    Guest lecturer: Deborah Knapp.

  14. BME 695L: Engineering Nanomedical Systems

    31 Aug 2011 | | Contributor(s):: James Leary

    This course will cover the basic concepts of design of integrated nanomedical systems for diagnostics and therapeutics. Topics to be covered include: why nanomedical approaches are needed, cell targeting strategies, choice of core nanomaterials, technologies for testing composition and structure...

  15. BME 695N Lecture 18: Designing nanodelivery systems for in-vivo use

    12 Nov 2007 | | Contributor(s):: James Leary

    Outline:Overview – the in-vitro to ex-vivo to in-vivo paradigm In-vitro - importance of choosing suitable cell lines Ex-vivo – adding the complexity of in-vivo background while keeping the simplicity of in-vitro In-vivo - all the complexity of ex-vivo plus the “active” components of a real...

  16. BME 695N Lecture 19: In vivo model systems to study nanomedical approaches to cancer detection and intervention

    27 Nov 2007 | | Contributor(s):: Deborah W Knapp

    With Deborah Knapp as guest lecturer.

  17. BME 695N: Engineering Nanomedical Systems (Fall 2007)

    03 Aug 2007 | | Contributor(s):: James Leary

    This course will cover the basic concepts of design of integrated nanomedical systems for diagnostics and therapeutics. Topics to be covered include: why nanomedical approaches are needed, cell targeting strategies, choice of core nanomaterials, technologies for testing composition and structure...

  18. Cancer Care Engineering

    31 Jan 2011 | | Contributor(s):: Joseph Pekny

  19. Development of Highly Porous Large Polymeric Microparticles for Sustained Local Drug Delivery to the Lung

    10 Jul 2008 | | Contributor(s):: Yoon Yeo

    In this presentation, I will introduce a new way of making highly porous large polymeric microparticles recently developed in my lab. These microparticles exhibited desirable aerodynamic properties, reduced macrophage uptake, encapsulated a drug efficiently, and provided sustained drug release...

  20. Functionalized Nanomaterials at the Interface of Biology and Technology

    24 Apr 2008 | | Contributor(s):: Dean Ho, National Center for Learning & Teaching in Nanosca

    Nanomaterials, such as block copolymeric membranes and nanodiamonds, can be engineered for a broad range of applications in energy and medicine. This presentation will highlight the relevance of these materials as foundations for device fabrication across the spectrum of biology and technology....